IL10 and cancer: Cancer-derived miR-214, for instance, can promote the proliferation of CD4+ CD25 high Forkhead Box P3 (FoxP3) + Regulatory T cells (Tregs) by addressing PTEN and stimulating IL-10 production, resulting in host immune repression and accelerated tumor progression (183).